Abstract
The regulation of cell adhesion and motility in human prostate is not well understood. We have previously shown that the endoglin gene is differently expressed during changes in prostate cell adhesion. Endoglin is a transmembrane transforming growth factor β binding protein typically expressed by endothelial cells. In this report we demonstrate that endoglin over expression increases prostate cell attachment, while decreasing migration and invasion. Engineered decreases in endoglin expression have opposite effects. While endoglin exerted only relatively small effects upon cell adhesion, large effects upon cell migration and invasion were observed. Endoglin was shown to localize to focal adhesion plaques, consistent with its role in regulating cell adhesion and motility. Loss of endoglin expression in cancer, as compared to normal prostate, was seen in human prostate cell lines. Suppression of endoglin expression in a panel of normal human prostate cell lines led to cell detachment. Endoglin is identified as a regulator of cell adhesion, motility and invasion in human prostate. Loss of endoglin expression appears to be associated with prostate cancer progression, at least in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- FAK:
-
focal adhesion kinase
- HPV:
-
human papillomavirus
- PBS:
-
phosphate buffered saline
- SDS:
-
sodium dodecyl sulfate
- PAGE:
-
polyacrylamide gel electrophoresis
- PCR:
-
polymerase chain reaction
- PMSF:
-
phenylmethylsulfonylfluoride
- HRP:
-
horse radish peroxidase
- FCS:
-
fetal calf serum
- MTT:
-
dimethylthiazoldiphenytetrazolium bromide
- FACS:
-
flow activated cell sorting
References
Albo D, Berger DH, Wang TN, Hu X, Rothman V, Tuszynski GP . 1997 Surgery 122: 493–499 discussion 499-500
Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, Nicotra MR, Cattelan A, Natali PG, Maio M . 1996 Br. J. Cancer 74: 1586–1591
Barbara NP, Wrana JL, Letarte M . 1999 J. Biol. Chem. 274: 584–594
Bellon T, Corbi A, Lastres P, Cales C, Cebrian M, Vera S, Cheifetz S, Massague J, Letarte M, Bernabeu C . 1993 Eur. J. Immunol. 23: 2340–2345
Bergan R, Connell Y, Fahmy B, Kyle E, Neckers L . 1994 Nucleic Acids Res. 22: 2150–2154
Bergan R, Connell Y, Fahmy B, Neckers L . 1993 Nucleic Acids Res. 21: 3567–3573
Bergan R, Hakim F, Schwartz GN, Kyle E, Cepada R, Szabo JM, Fowler D, Gress R, Neckers L . 1996a Blood 88: 731–741
Bergan R, Kyle E, Nguyen P, Trepel J, Ingui C, Neckers L . 1996b Clin. Exp. Metastasis 14: 389–398
Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM, Topalian SL . 1997 Cancer Res. 57: 995–1002
Cai T, Lei QY, Wang LY, Zha XL . 2000 Biochem. Biophys. Res. Commun. 274: 519–525
Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M . 1992 J. Biol. Chem. 267: 19027–19030
Cress AE, Rabinovitz I, Zhu W, Nagle RB . 1995 Cancer Metastasis Rev. 14: 219–228
Dakhama A, Macek V, Hogg JC, Hegele RG . 1996 J. Histochem. Cytochem. 44: 1205–1207
Eckstein F, Krieg AM, Stein CA, Agrawal S, Beaucage S, Cook PD, Crooke S, Gait MJ, Gewirtz A, Helene C, Miller P, Narayanan R, Nicolin A, Nielsen P, Ohtsuka E, Seliger H, Stec W, Tidd D, Wagner R, Zon J . 1996 Antisense Nucleic Acid Drug Dev. 6: 149
Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D, Teti A . 1999 Int. J. Cancer 81: 395–403
Fornaro M, Tallini G, Bofetiado CJ, Bosari S, Languino LR . 1996 Am. J. Pathol. 149: 765–773
Fornaro M, Tallini G, Zheng DQ, Flanagan WM, Manzotti M, Languino LR . 1999 J. Clin. Invest. 103: 321–329
Games PA, Howell JF . 1976 J. Educational Statistics 1: 113–126
Giancotti FG, Ruoslahti E . 1999 Science 285: 1028–1032
Goldfinger LE, Hopkinson SB, deHart GW, Collawn S, Couchman JR, Jones JC . 1999 J. Cell Sci. 112: 2615–2629
Gougos A, Letarte M . 1990 J. Biol. Chem. 265: 8361–8364
Guerrero-Esteo M, Lastres P, Letamendia A, Perez-Alvarez MJ, Langa C, Lopez LA, Fabra A, Garcia-Pardo A, Vera S, Letarte M, Bernabeu C . 1999 Eur. J. Cell Biol. 78: 614–623
Hanks SK, Polte TR . 1997 Bioessays 19: 137–145
Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N . 2000 Nat. Med. 6: 41–48
Jovanovic B, Huang S, Liu YQ, Naguib KN, Bergan RC . 2001 Am. J. PharmacoGenomics 1: 145–152
Jovanovic BD, Huang S, Liu YQ, Naguib K, Bergan RC (eds) . 2002 An analysis of gene array data related to cell adhesion and prostate cancer Boston: Kluwer Academic Publishers
Kozlowski JM, Isaiah JF, Campbell D, Xu ZL, Kaighn ME, Hart IR . 1984 Cancer Res. 44: 3522–3529
Kyle E, Neckers L, Takimoto C, Curt G, Bergan R . 1997 Mol. Pharmacol. 51: 193–200
Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C . 1996 J. Cell Biol. 133: 1109–1121
Lastres P, Martin-Perez J, Langa C, Bernabeu C . 1994 Biochem. J. 301: (Pt 3) 765–768
Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C . 1998 J. Biol. Chem. 273: 33011–33019
Liu YQ, Kyle E, Patel S, Housseau F, Hakim F, Lieberman R, Pins M, Blagosklonny M, Bergan C . 2001 Pros. Ca. Prostatic Diseases 4: 1–11
Liu YU, Kyle E, Lieberman R, Crowell J, Kelloff G, Bergan RC . 2000 Clin. and Exp. Metastasis 18: 203–212
Loganadane LD, Vassy J, Legrand C, Fauvel-Lafeve F . 1999 Cell Adhes. Commun. 7: 57–71
Luo J, Sharma N, Seftor EA, De Larco J, Heidger PM, Hendrix MJ, Lubaroff DM . 1997 Pathol. Oncol. Res. 3: 264–271
McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, Marchuk DA . 1995 Hum. Mol. Genet. 4: 1983–1985
Meredith Jr J, Takada Y, Fornaro M, Languino LR, Schwartz MA . 1995 Science 269: 1570–1572
Merzak A, McCrea S, Koocheckpour S, Pilkington GJ . 1994 Br. J. Cancer 70: 199–203
Nagle RB, Knox JD, Wolf C, Bowden GT, Cress AE . 1994 J. Cell Biochem. Suppl 19: 232–237
Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M . 1999 Hum. Mol. Genet. 8: 2171–2181
Sastry SK, Burridge K . 2000 Exp. Cell Res. 261: 25–36
Schoenenberger CA, Zuk A, Zinkl GM, Kendall D, Matlin KS . 1994 J. Cell Sci. 107: 527–541
Schwartz GN, Liu YQ, Tisdale J, Walshe K, Fowler D, Gress R, Bergan RC . 1998 Antisense Nucleic Acid Drug Dev. 8: 329–339
Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger Jr PM, Cohen MB, Lubaroff DM, Hendrix MJ . 2002 Prostate 50: 189–201
Takahashi N, Kawanishi-Tabata R, Haba A, Tabata M, Haruta Y, Tsai H, Seon BK . 2001 Clin. Cancer Res. 7: 524–532
Teti A, De Giorgi A, Spinella MT, Migliaccio S, Canipari R, Onetti Muda A, Faraggiana T . 1997 Int. J. Cancer 72: 1013–1020
Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A, Chevalier S . 1996 Int. J. Cancer 68: 164–171
Witkowski CM, Rabinovitz I, Nagle RB, Affinito KS, Cress AE . 1993 J. Cancer Res. Clin. Oncol. 119: 637–644
Yamada KM . 1997 Matrix Biol. 16: 137–141
Acknowledgements
We would like to thank Dr Carmelo Bernabeu for providing us with endoglin vectors. This work was supported in part by a Prostate SPORE grant from the National Cancer Institute CA90386, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Jovanovic, B., Pins, M. et al. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 21, 8272–8281 (2002). https://doi.org/10.1038/sj.onc.1206117
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206117
Keywords
This article is cited by
-
Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma
Cancer Immunology, Immunotherapy (2023)
-
Can serum endoglin be used to improve the diagnostic performance in prostate cancer?
World Journal of Urology (2021)
-
Precision therapeutic targeting of human cancer cell motility
Nature Communications (2018)
-
The role of endoglin in post-ischemic revascularization
Angiogenesis (2017)
-
Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis
Journal of Biomedical Science (2016)